MAG
DMTK

Mayfair Advisory Group’s DermTech, Inc. Common Stock DMTK Stock Holding History

Mayfair Advisory Group’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,400
Closed -$18.6K – 140
2023
Q3 		$18.6K Sell
12,400
-2,600
-17% -$6.5K 0.02% 124
2023
Q2 		$44.9K Buy
15,000
+2,000
+15% +$5.98K 0.04% 125
2023
Q1 		$54K Buy
+13,000
New +$54.7K 0.06% 118

Other funds holding DMTK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

Mayfair Advisory Group's DMTK Position: Q4 2023 in Review

Mayfair Advisory Group sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 12,400 shares — an estimated $18.6K sold.

Mayfair Advisory Group first reported a position in DMTK in Q1 2023 and held it in 3 quarters. The position peaked at $54K in Q1 2023. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

  • Mayfair Advisory Group reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Mayfair Advisory Group sold 12,400 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $18.6K.
  • Mayfair Advisory Group first reported a position in DermTech, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Mayfair Advisory Group's DermTech, Inc. Common Stock position peaked at $54K in Q1 2023.
  • 77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on Mayfair Advisory Group's 13F filing for Q4 2023, filed 19 Jan 2024.